CarthroniX

CarthroniX is a biopharmaceutical company focused on developing small molecule-based drugs to treat degenerative and aging-related diseases, including arthritis. Our new technology can preserve, repair, and regenerate cartilage in joints while suppressing inflammation. We are also developing entirely new solutions for wound healing, skin regeneration, and the prevention of tissue fibrosis in skin and musculoskeletal tissues. Our discoveries are based on science conducted by world-class researchers from leading institutions.